Gallen subtype classification, introduced in 2011, categorizes breast cancer into luminal A, luminal B HER2-neu negative, luminal B HER2-neu positive, HER2-neu non-luminal, and triple negative breast cancer (TNBC) based on immunohistochemical staining (2). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.